(PRESS RELEASE) ROCHESTER, N.Y. — CooperVision is reinforcing its leadership in U.S. myopia care by more than doubling its myopia sales team. This expansion establishes a new industry benchmark and underscores the company’s ongoing efforts to advance the field. At Academy 2024 in Indianapolis, CooperVision will showcase this enhanced commitment alongside the latest innovations and collaborations shaping the future of children’s eye health.
“Our expanded group of myopia experts are dedicated to offering nationwide support to practices with comprehensive solutions, including MiSight 1 day, and Paragon CRT” said Tony Sommer, General Manager, Myopia & Specialty Americas, CooperVision. “This investment extends beyond our team—it’s a pledge to elevate myopia management as the standard of care. With over 150,000 children worldwide wearing MiSight 1 day soft contact lenses, our determination to expand this impact has never been stronger.”
The myopia sales team plays an essential role in supporting CooperVision’s entire myopia management portfolio, offering personalized guidance and expertise to help eye care professionals (ECPs) successfully implement these innovative solutions. Their help and support empower more ECPs to tackle myopia and deliver optimal care for their young patients.
At Academy 2024, CooperVision will feature its interactive “CooperVision Elementary” booth, where attendees can experience a typical school day through the eyes of a child with myopia. The company will also present new myopia management research, featuring studies on the effectiveness of MiSight 1 day, orthokeratology, clinical practice trends, and the real-world myopia control results of these approaches.
“We’re fully committed to investing the necessary resources to drive meaningful change, particularly when it comes to children’s eye health. We’ll continue pushing forward to create a lasting positive impact for children with myopia,” added Sommer.
For more information about Academy 2024, visit here or stop by CooperVision’s booth #808.
Advertisement
